JPMorgan Equity Premium Income ETF Sees Inflows Amid Pullback

JPMorgan Equity Premium Income ETF ( $JEPI ) has fallen by 2.60% in the past week. It has experienced a 5-day net inflow of $213.5 million.
This is due, in part, to market sentiment on some of the ETF’s largest holdings. For example:

• Johnson & Johnson shares have climbed nearly 50% over the past year, and despite a recent pullback, analysts remain broadly positive, with a Moderate Buy rating and 12‑month targets around $253, implying mid‑single‑digit upside. Optimism is fueled by the U.S. FDA’s early approval of Icotyde for plaque psoriasis, which could become a multi‑billion‑dollar franchise and anchor a new growth cycle.
• Ross Stores is seeing profit‑taking after hitting fresh 52‑week highs, with the stock pressured by broader weakness in consumer discretionary names and some insider selling rather than any shift in fundamentals. Wall Street still rates the discount retailer a Strong Buy, with Goldman Sachs and others targeting roughly $233–$244, implying low‑teens upside from recent levels.
• NextEra Energy Inc. secured presidential approval to develop up to 10 gigawatts of gas‑fired power in Texas and Pennsylvania under a U.S.-Japan partnership, significantly expanding its long‑term project pipeline as data centers and industry drive power demand. Analysts keep a Moderate Buy stance, with price targets around $95–$98 suggesting modest upside while highlighting the company’s role in a major U.S. generation build‑out.